The US Food and Drug Administration has approved the stimulant lisdexamfetamine to treat binge-eating disorder, the first product to be approved for the condition.
The FDA is seeking a cap on nicotine levels in cigarettes and certain tobacco products at minimally or nonaddictive levels. This initiative, if finalized, would be what the FDA calls a “significant step”...
The FDA has approved new options for the treatment of obesity and blood clots associated with deep-vein thrombosis and atrial fibrillation, and the diagnosis of influenza that healthcare providers should be...
The FDA has approved new options for the treatment of hepatitis C, ovarian cancer, and urinary tract infections that healthcare providers should be aware of.
The FDA has warned of the possibility of serious and sometimes fatal skin reactions associated with an antipsychotic used to treat schizophrenia and bipolar disorder.
